Hikma Searches For Strategic ‘Fourth Leg’

Considering Deals For Specialty Or Biologic Injectables

 
• By Aidan Fry
  
Dog
Hikma's CEO Siggi Olafsson is looking to add a 'fourth leg' to the group's offering • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business